There is a history of competition law being used to drive HIV medicine prices lower in South Africa. Now, two cases involving cancer medicines seem set to nail down what qualifies as “excessive pricing” in South African law – a legal development that could have far reaching implications for medicines prices in the country. Catherine Tomlinson unpacks the details.
HIV activist Solly Nduku was recently elected to the top civil society position at SANAC. Thabo Molelekwa asked Nduku and his newly elected deputies about their plans and priorities for the council.
A Competition Commission probe recently resulted in a patent on an important tuberculosis medicine being dropped in South Africa. Twenty years ago, a similar Competition Commission case resulted in a settlement that helped drive down the prices of several antiretrovirals, thereby helping to set the stage for the country’s HIV treatment programme. Fatima Hassan and Leena Menghaney connect the dots between the two landmark cases and map out what has and has not changed over the last two decades.
In this hard-hitting open letter, SECTION27, Cancer Alliance and TAC activists argue that the Gauteng Department of Health has failed in fulfilling its obligations to provide radiation oncology services while over 3 000 cancer patients wait for treatment.
Some health activists and health professionals this week slammed as disruptive and nonsensical Eastern Cape Premier Oscar Mabuyane’s decision to ‘second’ the head of health in the province, Dr Rolene Wagner, to a special unit in his office. Many have expressed concern over the impact this may have on providing health services, but Mabuyane insists his decision will not impact service delivery. Luvuyo Mehlwana reports.
A pivotal case for access to affordable medicines in South Africa is set to determine whether people in South Africa will be able to get access to breakthrough cystic fibrosis treatments. Aneesa Adams spent some time with a family living with cystic fibrosis to get a sense of what is at stake.
The 11th South African AIDS Conference – the first since COVID-19-related disruptions – kicked off on Tuesday in Durban. This year’s theme is, “Act, Connect and End the Epidemic”. Spotlight summarises some key themes that emerged from the opening ceremony and spoke to some delegates.
Cystic fibrosis (CF) is a debilitating and often deadly disease. Until recently, the only treatments for its symptoms were difficult to administer and time-consuming. Life-changing new treatments that dramatically improve the prognosis for people with the disease have been developed, but they are expensive and Vertex, the US company making the drugs, has decided against registering the drugs in South Africa. Cheri Nel, a woman living with CF, is now taking Vertex on in a South African court. Catherine Tomlinson unpacks the details.
The quest for access to equitable and quality surgical care for all will not be won only in board rooms, theatres, or hospital corridors. We have to take this quest into communities and build alliances. In that respect, we can learn from one of the best examples of how community participation and mobilisation can help change health policy – the movement to ensure access to affordable and universal anti-retroviral treatment for persons living with HIV, argues Professor Kathryn Chu and Sangeun Lee.
Staff attitudes and patients complaining of being treated badly by healthcare workers at some clinics in the Eastern Cape were among the issues flagged in the latest report by community-led clinic monitoring group Ritshidze. Luvuyo Mehlwana reports.
National Health Insurance (NHI) was one of the hot topics at the 2022 Public Health Association of South Africa Conference recently held in Durban. While several speakers and attendees expressed support for the principles underpinning NHI, many also expressed reservations. Elri Voigt assesses what the conference told us about the views of some of South Africa’s public health experts on NHI.
The Treatment Action Campaign (TAC) elected new leadership at its recently held seventh national congress. Thabo Molelekwa attended the congress and asked TAC leaders about the organisation’s focus in 2022 and beyond.
